AIMing for Tokyo

Drug delivery cancer play Mebiopharm is the first to apply to list on Tokyo AIM

Tokyo AIM finally looks to be getting its first-ever listing, as drug delivery cancer

Read the full 143 word article

How to gain access

Continue reading with a
two-week free trial.